In a serial of human liver diseases that mimic the progression of HCC transformation, i.e., from normal liver, to fibrotic liver, to dysplastic nodule, to HCC, we found increased GLS1 expression at each step, while GLS2 was significantly down-regulated in HCC. This evidence concerns the gene GLS2 and liver disorder.